Stock Events

Stock Events

Iovance Biotherapeutics (0JDK.LSE) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.36

-0.32

-0.28

-0.24

Details

Expected EPS

-0.241721

Actual EPS

-0.36

Surprise EPS

-0.12

Surprise Percent

+48.93%

Description

Iovance Biotherapeutics (0JDK.LSE) has reported earnings of -0.36 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.